Literature DB >> 6595668

Interferon induces pulmonary cysts in A2G mice.

D Woodrow, J Moss, I Gresser.   

Abstract

Suckling A2G mice were treated for the first week of life with either partially purified or electrophoretically pure mouse alpha/beta interferon. All mice subsequently developed multiple large pulmonary cysts. The lesions were never found in interferon-treated Swiss mice and only very infrequently in interferon-treated BALB/c or F1 Swiss/A2G mice. These observations show that a brief exposure of suckling A2G mice to alpha/beta interferon can result in a severe disease that is determined by the mouse genotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6595668      PMCID: PMC392268          DOI: 10.1073/pnas.81.24.7937

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Lethality of interferon preparations for newborn mice.

Authors:  I Gresser; M G Tovey; C Maury; I Chouroulinkov
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

2.  THE RESISTANCE OF A2G MICE TO MYXOVIRUSES.

Authors:  J LINDENMANN; C A LANE; D HOBSON
Journal:  J Immunol       Date:  1963-06       Impact factor: 5.422

3.  Congenital pulmonary lymphangiectasis.

Authors:  K M LAURENCE
Journal:  J Clin Pathol       Date:  1959-01       Impact factor: 3.411

4.  Progressive glomerulonephritis in mice treated with interferon preparations at birth.

Authors:  I Gresser; C Maury; M Tovey; L Morel-Maroger; F Pontillon
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

5.  A method for the large scale production of potent interferon preparations.

Authors:  M G Tovey; J Begon-Lours; I Gresser
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

6.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice.

Authors:  I Gresser; M Aguet; L Morel-Maroger; D Woodrow; F Puvion-Dutilleul; J C Guillon; C Maury
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

7.  Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period.

Authors:  I Gresser; L Morel-Maroger; F Châtelet; C Maury; M Tovey; M T Bandu; J Buywid; M Delauche
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

8.  Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus.

Authors:  J Gresser; L Morel-Maroger; P Verroust; Y Rivière; J C Guillon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

9.  Antigenic correlations between components of C243 and L cell interferons.

Authors:  Y Kawade; M Aguet; M G Tovey
Journal:  Antiviral Res       Date:  1982-08       Impact factor: 5.970

10.  Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice.

Authors:  Y Rivière; I Gresser; J C Guillon; M G Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

View more
  4 in total

1.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

2.  Interferon alpha/beta induces changes in the metabolism of polyenoic phospholipids and diacylglycerols in the livers of suckling mice.

Authors:  G Zwingelstein; G Brichon; R Meister; C Maury; I Gresser
Journal:  Lipids       Date:  1987-10       Impact factor: 1.880

3.  Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta.

Authors:  I Gresser; D Woodrow; J Moss; C Maury; J Tavernier; W Fiers
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

4.  Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

Authors:  L Gabriele; T Kaido; D Woodrow; J Moss; M Ferrantini; E Proletti; L Santodonato; C Rozera; C Maury; F Belardelli
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.